Nadezhda Kurashova

Dr. Nadezhda Kurashova


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Advances in Gerontology
Verified
Journal Article
Closed access
PDF file
NKNadezhda Kurashova
Nadezhda Kurashova
IMI. M. Madaeva
I. M. Madaeva
LKL. I. Kolesnikova
L. I. Kolesnikova
The development of oxidative stress inevitably causes damage to cell proteins in need of timely refolding. The synthesis of the proteins of the heat-shock group is the most ancient and effective mechanism of cell protection. The life-long cellular adaptation to a huge number of cytotoxic factors, both of xenobiotic and natural origin, have provided heat-shock proteins with polyfunctionality: in the processes of programmed death, they act as either anti- or pro-apoptogenic factors or as regulators of the activity of these factors. The important role of heat-shock proteins in adaptation, inflammation, and immune response had also been shown. Various experimental and clinical studies confirmed the important role of heat-shock proteins in the development of pathophysiological phenomena of oxidative stress, aging, tumor formation, and immune reactions. The data presented in the review includes domestic and foreign studies on the physiological significance of heat-shock proteins, their role in the mechanisms of cell, and body stability in general and are relevant to modern medicine and biology.

3 December 2015 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Open access
PDF file
LKL. I. Kolesnikova
L. I. Kolesnikova
Sergey I. KolesnikovSergey I. Kolesnikov
Sergey I. Kolesnikov
NKNadezhda Kurashova
Nadezhda Kurashova
TBT. A. Bairova
T. A. Bairova
КИКолесникова Л. И.
Колесникова Л. И.
БАБаирова Т. А.
Баирова Т. А.
The preservation of reproductive health of the population is an important factor of demographic policy of the state. According to some authors from 14 to 30% of couples of reproductive age suffer from infertility, male factor in such marriages is detected in more than half of the cases. As you know, in recent years there has been a significant deterioration in the main indicators of reproductive function of men. Increased the number of andrological diseases, morphological disorders of the male reproductive system, almost halved the production of sperm in men of reproductive age. The reason probably lies behind a whole range of stress factors, such as medical ignorance, uncontrolled and inappropriate use of medication, metabolic disturbances, lack of vitamins and minerals, the impact of industrial pollutants, as well as the growth of addictive disorders (alcoholism, smoking and drug addiction). The forms of infertility differ according to its etiology and severity from minor changes to complete spermatogenesis dysfunction of the gonads, and can also occur due to genetic disorders. The lack of analysis of the relationship between clinical and genetic-biochemical components in men with infertility makes it impossible to understand the pathogenesis of infertility and to assess the risks of male infertility. High level of current medicine does not always guarantee an identification of the cause of male infertility. The article analyzes data from the review of specialized literature on the diagnosis and etiopathogenesis of male infertility. Frequency and clinical signs of pathology of the male reproductive system depend on the combinatorial effects of environmental influences, manifested most often in mutually reinforcing effect. A combination of several, seemed to be imperceptible factors makes the risk of development of male reproductive pathology very high. This situation compels specialists to conduct comprehensive studies on the men reproductive potential.

1 January 2019
Verified
Journal Article
Closed access
NKNadezhda Kurashova
Nadezhda Kurashova
IMI M Madaeva
I M Madaeva
LKLiubov Kolesnikova
Liubov Kolesnikova

25 September 2017 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
LKL. I. Kolesnikova
L. I. Kolesnikova
NKNadezhda Kurashova
Nadezhda Kurashova
TBT. A. Bairova
T. A. Bairova
MDM. I. Dolgikh
M. I. Dolgikh
OEO. A. Ershova
O. A. Ershova
NKN. V. Koroleva
N. V. Koroleva

1 January 2022 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
IMIrina Madaeva
Irina Madaeva
NKNadezhda Kurashova
Nadezhda Kurashova
EUE.B. Ukhinov
E.B. Ukhinov
OBOlga Berdina
Olga Berdina
NSNatalya Semenova
Natalya Semenova
Sergey I. KolesnikovSergey I. Kolesnikov
Sergey I. Kolesnikov
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить относительную длину теломер (ОДТ) у пациентов с синдромом обструктивного апноэ (СОАС) до и после 6-месячного курса терапии созданием постоянного положительного давления воздуха в дыхательных путях (СИПАП-терапия). МАТЕРИАЛ И МЕТОДЫ В исследовании участвовали 75 мужчин, средний возраст 53,4±3,6 года. Основную группу (ОГ1) составили 50 мужчин с СОАС; полностью завершили исследование 35 мужчин — ОГ2. Контрольную группу (КГ) составили 25 мужчин без СОАС. Согласно дизайну исследования, всем была проведена ночная полисомнография (ПСГ); забор крови для оценки ОДТ осуществлялся утром по стандартной методике. Значения ОДТ получали, используя разницу между значениями пороговых циклов для теломерной ДНК и референсного гена альбумина (∆Ct). После уточнения диагноза была применена СИПАП-терапия в течение 6 мес. РЕЗУЛЬТАТЫ Выявлены статистически значимые показатели ПСГ: снижение глубоких стадий сна у пациентов с СОАС в сравнении с КГ (89,3±15,8 мин против 150±23,4 мин), увеличение поверхностных стадий при СОАС (296,2±31,1 и 170,1±24,5 мин соответственно), сокращение времени фазы быстрого сна (ФБС) (84,6±15,4 и 118,5±19,5 мин). Проведение в течение 6 мес постоянной СИПАП-терапии (не менее 4—5 ночей в 1 нед, длительностью не менее 5—6 ч ночного сна) положительно повлияло на качественные и количественные параметры сна. У лиц ОГ1 отмечалось укорочение ОДТ, по сравнению с мужчинами КГ (p<0,001). При устранении гипоксии и улучшении структуры сна после СИПАП-терапии отмечено увеличение показателя ОДТ в ОГ1 с 0,28 [0,24—0,29] до 0,32 [0,30—0,34] в ОГ2 (p=0,003). Медиана данного показателя в КГ составила 0,53 [0,50—0,55]. ЗАКЛЮЧЕНИЕ Интермиттирующая гипоксия и фрагментация сна при СОАС приводят к укорочению теломер. СИПАП-терапия, устраняя патофизиологические триггеры СОАС, способствует увеличению ОДТ в концевых участках хромосом и может замедлить преждевременное старение организма при СОАС.

20 October 2021 in Neurology and Therapy
Verified
Journal Article
Open access
PDF file
IMIrina Madaeva
Irina Madaeva
OBOlga Berdina
Olga Berdina
NKNadezhda Kurashova
Nadezhda Kurashova
NSNatalya Semenova
Natalya Semenova
EUErdem B. Ukhinov
Erdem B. Ukhinov
LKLyubov I. Kolesnikova
Lyubov I. Kolesnikova
Introduction The high prevalence of obstructive sleep apnea (OSA), which impairs quality of life for numerous patients and leads to various OSA complications, has contributed to the continued interest in this disorder. The role of serotonin (5-HT) in many physiological processes, studies on its connection with the circadian system, and relationship to changes in sleep architecture are insufficient to assess the interaction of this neurotransmitter with nocturnal hypoxia. The aim of this study was to determine changes in sleep patterns and serum serotonin levels before and after positive airway pressure (PAP) therapy in patients with OSA. Methods The study involved 30 OSA patients (27 men and 3 women) who were treated with PAP for 3 months. Polysomnography using the GRASS TELEFACTOR (USA) and blood collection were conducted before and after PAP courses. Determination of serum serotonin was performed by high-performance liquid chromatography (HPLC). PAP therapy was performed using an automatic Prisma 20A (Germany) continuous positive airway pressure (CPAP) device. Results The use of PAP for 3 months revealed a significant improvement as measured by sleep data and serotonin levels (before: apnea index [AI] 17.2 eV/h, after: 2.4 eV/h p = 0.001; SpO2 < 90% − 45.7 min vs. 6.2 min p = 0.001; serotonin 20.3 ng/mL vs. 26.03 ng/mL p = 0.036]. Conclusion Our results demonstrate an improvement in sleep patterns. There was an increase in serum serotonin levels in OSA patients following PAP therapy, which could be an effect of intermittent hypoxia decline, and could be used as criteria for the effectiveness of PAP and an improvement in sleep quality.